nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—CYP1A2—Dacarbazine—pancreatic cancer	0.0769	0.159	CbGbCtD
Rotigotine—CYP1A2—Tamoxifen—pancreatic cancer	0.0612	0.127	CbGbCtD
Rotigotine—CYP1A2—Erlotinib—pancreatic cancer	0.052	0.108	CbGbCtD
Rotigotine—CYP2D6—Tamoxifen—pancreatic cancer	0.0504	0.104	CbGbCtD
Rotigotine—CYP1A2—Fluorouracil—pancreatic cancer	0.0451	0.0934	CbGbCtD
Rotigotine—CYP2D6—Erlotinib—pancreatic cancer	0.0428	0.0888	CbGbCtD
Rotigotine—CYP3A4—Tamoxifen—pancreatic cancer	0.032	0.0664	CbGbCtD
Rotigotine—CYP3A4—Erlotinib—pancreatic cancer	0.0272	0.0564	CbGbCtD
Rotigotine—CYP3A4—Irinotecan—pancreatic cancer	0.0246	0.051	CbGbCtD
Rotigotine—CYP2D6—Doxorubicin—pancreatic cancer	0.0211	0.0438	CbGbCtD
Rotigotine—CYP3A4—Docetaxel—pancreatic cancer	0.018	0.0373	CbGbCtD
Rotigotine—CYP3A4—Sunitinib—pancreatic cancer	0.0179	0.0372	CbGbCtD
Rotigotine—CYP3A4—Doxorubicin—pancreatic cancer	0.0134	0.0278	CbGbCtD
Rotigotine—Hypotension—Irinotecan—pancreatic cancer	0.000509	0.00149	CcSEcCtD
Rotigotine—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.000506	0.00148	CcSEcCtD
Rotigotine—Anorexia—Gemcitabine—pancreatic cancer	0.000506	0.00148	CcSEcCtD
Rotigotine—Dizziness—Erlotinib—pancreatic cancer	0.000505	0.00148	CcSEcCtD
Rotigotine—Anorexia—Fluorouracil—pancreatic cancer	0.000497	0.00145	CcSEcCtD
Rotigotine—Hypotension—Gemcitabine—pancreatic cancer	0.000496	0.00145	CcSEcCtD
Rotigotine—Insomnia—Irinotecan—pancreatic cancer	0.000492	0.00144	CcSEcCtD
Rotigotine—Vomiting—Tamoxifen—pancreatic cancer	0.000491	0.00143	CcSEcCtD
Rotigotine—Paraesthesia—Irinotecan—pancreatic cancer	0.000489	0.00143	CcSEcCtD
Rotigotine—Lethargy—Doxorubicin—pancreatic cancer	0.000488	0.00143	CcSEcCtD
Rotigotine—Hypotension—Fluorouracil—pancreatic cancer	0.000487	0.00142	CcSEcCtD
Rotigotine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000487	0.00142	CcSEcCtD
Rotigotine—Rash—Tamoxifen—pancreatic cancer	0.000487	0.00142	CcSEcCtD
Rotigotine—Dermatitis—Tamoxifen—pancreatic cancer	0.000486	0.00142	CcSEcCtD
Rotigotine—Vomiting—Erlotinib—pancreatic cancer	0.000485	0.00142	CcSEcCtD
Rotigotine—Somnolence—Irinotecan—pancreatic cancer	0.000484	0.00142	CcSEcCtD
Rotigotine—Headache—Tamoxifen—pancreatic cancer	0.000483	0.00141	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000483	0.00141	CcSEcCtD
Rotigotine—Rash—Erlotinib—pancreatic cancer	0.000481	0.00141	CcSEcCtD
Rotigotine—Dermatitis—Erlotinib—pancreatic cancer	0.000481	0.00141	CcSEcCtD
Rotigotine—Angiopathy—Docetaxel—pancreatic cancer	0.000481	0.00141	CcSEcCtD
Rotigotine—Insomnia—Gemcitabine—pancreatic cancer	0.00048	0.0014	CcSEcCtD
Rotigotine—Dyspepsia—Irinotecan—pancreatic cancer	0.000479	0.0014	CcSEcCtD
Rotigotine—Immune system disorder—Docetaxel—pancreatic cancer	0.000478	0.0014	CcSEcCtD
Rotigotine—Headache—Erlotinib—pancreatic cancer	0.000478	0.0014	CcSEcCtD
Rotigotine—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000477	0.0014	CcSEcCtD
Rotigotine—Paraesthesia—Gemcitabine—pancreatic cancer	0.000476	0.00139	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000475	0.00139	CcSEcCtD
Rotigotine—Asthenia—Sunitinib—pancreatic cancer	0.000474	0.00139	CcSEcCtD
Rotigotine—Decreased appetite—Irinotecan—pancreatic cancer	0.000473	0.00138	CcSEcCtD
Rotigotine—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000472	0.00138	CcSEcCtD
Rotigotine—Insomnia—Fluorouracil—pancreatic cancer	0.000472	0.00138	CcSEcCtD
Rotigotine—Somnolence—Gemcitabine—pancreatic cancer	0.000471	0.00138	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00047	0.00137	CcSEcCtD
Rotigotine—Fatigue—Irinotecan—pancreatic cancer	0.000469	0.00137	CcSEcCtD
Rotigotine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000468	0.00137	CcSEcCtD
Rotigotine—Pruritus—Sunitinib—pancreatic cancer	0.000468	0.00137	CcSEcCtD
Rotigotine—Breast disorder—Epirubicin—pancreatic cancer	0.000467	0.00136	CcSEcCtD
Rotigotine—Pain—Irinotecan—pancreatic cancer	0.000466	0.00136	CcSEcCtD
Rotigotine—Constipation—Irinotecan—pancreatic cancer	0.000466	0.00136	CcSEcCtD
Rotigotine—Mental disorder—Docetaxel—pancreatic cancer	0.000464	0.00136	CcSEcCtD
Rotigotine—Somnolence—Fluorouracil—pancreatic cancer	0.000464	0.00136	CcSEcCtD
Rotigotine—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000462	0.00135	CcSEcCtD
Rotigotine—Erythema—Docetaxel—pancreatic cancer	0.000461	0.00135	CcSEcCtD
Rotigotine—Malnutrition—Docetaxel—pancreatic cancer	0.000461	0.00135	CcSEcCtD
Rotigotine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000461	0.00135	CcSEcCtD
Rotigotine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000459	0.00134	CcSEcCtD
Rotigotine—Nausea—Tamoxifen—pancreatic cancer	0.000458	0.00134	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000458	0.00134	CcSEcCtD
Rotigotine—Fatigue—Gemcitabine—pancreatic cancer	0.000457	0.00134	CcSEcCtD
Rotigotine—Constipation—Gemcitabine—pancreatic cancer	0.000454	0.00133	CcSEcCtD
Rotigotine—Pain—Gemcitabine—pancreatic cancer	0.000454	0.00133	CcSEcCtD
Rotigotine—Nausea—Erlotinib—pancreatic cancer	0.000454	0.00133	CcSEcCtD
Rotigotine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000453	0.00133	CcSEcCtD
Rotigotine—Diarrhoea—Sunitinib—pancreatic cancer	0.000452	0.00132	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00045	0.00132	CcSEcCtD
Rotigotine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000449	0.00131	CcSEcCtD
Rotigotine—Pain—Fluorouracil—pancreatic cancer	0.000446	0.0013	CcSEcCtD
Rotigotine—Muscle spasms—Docetaxel—pancreatic cancer	0.000443	0.0013	CcSEcCtD
Rotigotine—Dizziness—Sunitinib—pancreatic cancer	0.000437	0.00128	CcSEcCtD
Rotigotine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000437	0.00128	CcSEcCtD
Rotigotine—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000436	0.00128	CcSEcCtD
Rotigotine—Breast disorder—Doxorubicin—pancreatic cancer	0.000432	0.00126	CcSEcCtD
Rotigotine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00043	0.00126	CcSEcCtD
Rotigotine—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000427	0.00125	CcSEcCtD
Rotigotine—Vomiting—Sunitinib—pancreatic cancer	0.00042	0.00123	CcSEcCtD
Rotigotine—Rash—Sunitinib—pancreatic cancer	0.000417	0.00122	CcSEcCtD
Rotigotine—Dermatitis—Sunitinib—pancreatic cancer	0.000416	0.00122	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000415	0.00121	CcSEcCtD
Rotigotine—Urticaria—Fluorouracil—pancreatic cancer	0.000414	0.00121	CcSEcCtD
Rotigotine—Headache—Sunitinib—pancreatic cancer	0.000414	0.00121	CcSEcCtD
Rotigotine—Syncope—Docetaxel—pancreatic cancer	0.000414	0.00121	CcSEcCtD
Rotigotine—Weight increased—Epirubicin—pancreatic cancer	0.000406	0.00119	CcSEcCtD
Rotigotine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000405	0.00119	CcSEcCtD
Rotigotine—Weight decreased—Epirubicin—pancreatic cancer	0.000404	0.00118	CcSEcCtD
Rotigotine—Cough—Docetaxel—pancreatic cancer	0.000402	0.00118	CcSEcCtD
Rotigotine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000401	0.00117	CcSEcCtD
Rotigotine—Hypertension—Docetaxel—pancreatic cancer	0.000398	0.00116	CcSEcCtD
Rotigotine—Infestation NOS—Epirubicin—pancreatic cancer	0.000398	0.00116	CcSEcCtD
Rotigotine—Infestation—Epirubicin—pancreatic cancer	0.000398	0.00116	CcSEcCtD
Rotigotine—Arthralgia—Docetaxel—pancreatic cancer	0.000393	0.00115	CcSEcCtD
Rotigotine—Nausea—Sunitinib—pancreatic cancer	0.000393	0.00115	CcSEcCtD
Rotigotine—Asthenia—Irinotecan—pancreatic cancer	0.000391	0.00114	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00039	0.00114	CcSEcCtD
Rotigotine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000384	0.00112	CcSEcCtD
Rotigotine—Dry mouth—Docetaxel—pancreatic cancer	0.000384	0.00112	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000384	0.00112	CcSEcCtD
Rotigotine—Asthenia—Gemcitabine—pancreatic cancer	0.000381	0.00111	CcSEcCtD
Rotigotine—Confusional state—Docetaxel—pancreatic cancer	0.000379	0.00111	CcSEcCtD
Rotigotine—Weight increased—Doxorubicin—pancreatic cancer	0.000376	0.0011	CcSEcCtD
Rotigotine—Pruritus—Gemcitabine—pancreatic cancer	0.000375	0.0011	CcSEcCtD
Rotigotine—Infection—Docetaxel—pancreatic cancer	0.000374	0.00109	CcSEcCtD
Rotigotine—Weight decreased—Doxorubicin—pancreatic cancer	0.000374	0.00109	CcSEcCtD
Rotigotine—Sinusitis—Epirubicin—pancreatic cancer	0.000373	0.00109	CcSEcCtD
Rotigotine—Diarrhoea—Irinotecan—pancreatic cancer	0.000373	0.00109	CcSEcCtD
Rotigotine—Shock—Docetaxel—pancreatic cancer	0.00037	0.00108	CcSEcCtD
Rotigotine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000369	0.00108	CcSEcCtD
Rotigotine—Pruritus—Fluorouracil—pancreatic cancer	0.000369	0.00108	CcSEcCtD
Rotigotine—Infestation NOS—Doxorubicin—pancreatic cancer	0.000368	0.00108	CcSEcCtD
Rotigotine—Infestation—Doxorubicin—pancreatic cancer	0.000368	0.00108	CcSEcCtD
Rotigotine—Skin disorder—Docetaxel—pancreatic cancer	0.000366	0.00107	CcSEcCtD
Rotigotine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000363	0.00106	CcSEcCtD
Rotigotine—Dizziness—Irinotecan—pancreatic cancer	0.00036	0.00105	CcSEcCtD
Rotigotine—Anorexia—Docetaxel—pancreatic cancer	0.000359	0.00105	CcSEcCtD
Rotigotine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000357	0.00104	CcSEcCtD
Rotigotine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000352	0.00103	CcSEcCtD
Rotigotine—Hypotension—Docetaxel—pancreatic cancer	0.000352	0.00103	CcSEcCtD
Rotigotine—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000351	0.00103	CcSEcCtD
Rotigotine—Vomiting—Irinotecan—pancreatic cancer	0.000346	0.00101	CcSEcCtD
Rotigotine—Sinusitis—Doxorubicin—pancreatic cancer	0.000346	0.00101	CcSEcCtD
Rotigotine—Dizziness—Fluorouracil—pancreatic cancer	0.000345	0.00101	CcSEcCtD
Rotigotine—Visual impairment—Epirubicin—pancreatic cancer	0.000344	0.00101	CcSEcCtD
Rotigotine—Rash—Irinotecan—pancreatic cancer	0.000343	0.001	CcSEcCtD
Rotigotine—Dermatitis—Irinotecan—pancreatic cancer	0.000343	0.001	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000343	0.001	CcSEcCtD
Rotigotine—Headache—Irinotecan—pancreatic cancer	0.000341	0.000997	CcSEcCtD
Rotigotine—Insomnia—Docetaxel—pancreatic cancer	0.00034	0.000996	CcSEcCtD
Rotigotine—Paraesthesia—Docetaxel—pancreatic cancer	0.000338	0.000988	CcSEcCtD
Rotigotine—Vomiting—Gemcitabine—pancreatic cancer	0.000337	0.000986	CcSEcCtD
Rotigotine—Somnolence—Docetaxel—pancreatic cancer	0.000335	0.000979	CcSEcCtD
Rotigotine—Rash—Gemcitabine—pancreatic cancer	0.000334	0.000978	CcSEcCtD
Rotigotine—Dermatitis—Gemcitabine—pancreatic cancer	0.000334	0.000977	CcSEcCtD
Rotigotine—Tinnitus—Epirubicin—pancreatic cancer	0.000333	0.000974	CcSEcCtD
Rotigotine—Headache—Gemcitabine—pancreatic cancer	0.000332	0.000972	CcSEcCtD
Rotigotine—Vomiting—Fluorouracil—pancreatic cancer	0.000332	0.00097	CcSEcCtD
Rotigotine—Dyspepsia—Docetaxel—pancreatic cancer	0.000331	0.000969	CcSEcCtD
Rotigotine—Rash—Fluorouracil—pancreatic cancer	0.000329	0.000962	CcSEcCtD
Rotigotine—Dermatitis—Fluorouracil—pancreatic cancer	0.000328	0.000961	CcSEcCtD
Rotigotine—Decreased appetite—Docetaxel—pancreatic cancer	0.000327	0.000957	CcSEcCtD
Rotigotine—Headache—Fluorouracil—pancreatic cancer	0.000327	0.000955	CcSEcCtD
Rotigotine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000326	0.000952	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000325	0.00095	CcSEcCtD
Rotigotine—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000325	0.00095	CcSEcCtD
Rotigotine—Fatigue—Docetaxel—pancreatic cancer	0.000324	0.000949	CcSEcCtD
Rotigotine—Angiopathy—Epirubicin—pancreatic cancer	0.000324	0.000948	CcSEcCtD
Rotigotine—Nausea—Irinotecan—pancreatic cancer	0.000323	0.000946	CcSEcCtD
Rotigotine—Immune system disorder—Epirubicin—pancreatic cancer	0.000323	0.000944	CcSEcCtD
Rotigotine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000322	0.000942	CcSEcCtD
Rotigotine—Pain—Docetaxel—pancreatic cancer	0.000322	0.000941	CcSEcCtD
Rotigotine—Constipation—Docetaxel—pancreatic cancer	0.000322	0.000941	CcSEcCtD
Rotigotine—Visual impairment—Doxorubicin—pancreatic cancer	0.000319	0.000932	CcSEcCtD
Rotigotine—Nausea—Gemcitabine—pancreatic cancer	0.000315	0.000921	CcSEcCtD
Rotigotine—Mental disorder—Epirubicin—pancreatic cancer	0.000313	0.000915	CcSEcCtD
Rotigotine—Malnutrition—Epirubicin—pancreatic cancer	0.000311	0.00091	CcSEcCtD
Rotigotine—Erythema—Epirubicin—pancreatic cancer	0.000311	0.00091	CcSEcCtD
Rotigotine—Feeling abnormal—Docetaxel—pancreatic cancer	0.00031	0.000907	CcSEcCtD
Rotigotine—Nausea—Fluorouracil—pancreatic cancer	0.00031	0.000906	CcSEcCtD
Rotigotine—Tinnitus—Doxorubicin—pancreatic cancer	0.000308	0.000901	CcSEcCtD
Rotigotine—Angiopathy—Doxorubicin—pancreatic cancer	0.0003	0.000877	CcSEcCtD
Rotigotine—Muscle spasms—Epirubicin—pancreatic cancer	0.000299	0.000875	CcSEcCtD
Rotigotine—Immune system disorder—Doxorubicin—pancreatic cancer	0.000299	0.000873	CcSEcCtD
Rotigotine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000298	0.000871	CcSEcCtD
Rotigotine—Mental disorder—Doxorubicin—pancreatic cancer	0.00029	0.000847	CcSEcCtD
Rotigotine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000289	0.000844	CcSEcCtD
Rotigotine—Erythema—Doxorubicin—pancreatic cancer	0.000288	0.000842	CcSEcCtD
Rotigotine—Malnutrition—Doxorubicin—pancreatic cancer	0.000288	0.000842	CcSEcCtD
Rotigotine—Agitation—Epirubicin—pancreatic cancer	0.000286	0.000836	CcSEcCtD
Rotigotine—Malaise—Epirubicin—pancreatic cancer	0.00028	0.00082	CcSEcCtD
Rotigotine—Vertigo—Epirubicin—pancreatic cancer	0.000279	0.000817	CcSEcCtD
Rotigotine—Syncope—Epirubicin—pancreatic cancer	0.000279	0.000816	CcSEcCtD
Rotigotine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000277	0.000811	CcSEcCtD
Rotigotine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000277	0.000809	CcSEcCtD
Rotigotine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000273	0.0008	CcSEcCtD
Rotigotine—Cough—Epirubicin—pancreatic cancer	0.000271	0.000794	CcSEcCtD
Rotigotine—Asthenia—Docetaxel—pancreatic cancer	0.00027	0.00079	CcSEcCtD
Rotigotine—Hypertension—Epirubicin—pancreatic cancer	0.000269	0.000785	CcSEcCtD
Rotigotine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000267	0.000781	CcSEcCtD
Rotigotine—Pruritus—Docetaxel—pancreatic cancer	0.000266	0.000779	CcSEcCtD
Rotigotine—Arthralgia—Epirubicin—pancreatic cancer	0.000265	0.000774	CcSEcCtD
Rotigotine—Agitation—Doxorubicin—pancreatic cancer	0.000264	0.000773	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000263	0.000769	CcSEcCtD
Rotigotine—Discomfort—Epirubicin—pancreatic cancer	0.000262	0.000765	CcSEcCtD
Rotigotine—Malaise—Doxorubicin—pancreatic cancer	0.00026	0.000759	CcSEcCtD
Rotigotine—Dry mouth—Epirubicin—pancreatic cancer	0.000259	0.000757	CcSEcCtD
Rotigotine—Vertigo—Doxorubicin—pancreatic cancer	0.000259	0.000756	CcSEcCtD
Rotigotine—Syncope—Doxorubicin—pancreatic cancer	0.000258	0.000755	CcSEcCtD
Rotigotine—Diarrhoea—Docetaxel—pancreatic cancer	0.000258	0.000753	CcSEcCtD
Rotigotine—Confusional state—Epirubicin—pancreatic cancer	0.000256	0.000749	CcSEcCtD
Rotigotine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000253	0.00074	CcSEcCtD
Rotigotine—Infection—Epirubicin—pancreatic cancer	0.000252	0.000738	CcSEcCtD
Rotigotine—Cough—Doxorubicin—pancreatic cancer	0.000251	0.000734	CcSEcCtD
Rotigotine—Shock—Epirubicin—pancreatic cancer	0.00025	0.00073	CcSEcCtD
Rotigotine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000249	0.000728	CcSEcCtD
Rotigotine—Dizziness—Docetaxel—pancreatic cancer	0.000249	0.000728	CcSEcCtD
Rotigotine—Hypertension—Doxorubicin—pancreatic cancer	0.000248	0.000727	CcSEcCtD
Rotigotine—Skin disorder—Epirubicin—pancreatic cancer	0.000247	0.000721	CcSEcCtD
Rotigotine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000245	0.000718	CcSEcCtD
Rotigotine—Arthralgia—Doxorubicin—pancreatic cancer	0.000245	0.000717	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000243	0.000712	CcSEcCtD
Rotigotine—Discomfort—Doxorubicin—pancreatic cancer	0.000242	0.000708	CcSEcCtD
Rotigotine—Anorexia—Epirubicin—pancreatic cancer	0.000242	0.000708	CcSEcCtD
Rotigotine—Dry mouth—Doxorubicin—pancreatic cancer	0.00024	0.000701	CcSEcCtD
Rotigotine—Vomiting—Docetaxel—pancreatic cancer	0.000239	0.0007	CcSEcCtD
Rotigotine—Rash—Docetaxel—pancreatic cancer	0.000237	0.000694	CcSEcCtD
Rotigotine—Hypotension—Epirubicin—pancreatic cancer	0.000237	0.000694	CcSEcCtD
Rotigotine—Dermatitis—Docetaxel—pancreatic cancer	0.000237	0.000693	CcSEcCtD
Rotigotine—Confusional state—Doxorubicin—pancreatic cancer	0.000237	0.000693	CcSEcCtD
Rotigotine—Headache—Docetaxel—pancreatic cancer	0.000236	0.00069	CcSEcCtD
Rotigotine—Infection—Doxorubicin—pancreatic cancer	0.000233	0.000682	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000231	0.000676	CcSEcCtD
Rotigotine—Shock—Doxorubicin—pancreatic cancer	0.000231	0.000676	CcSEcCtD
Rotigotine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00023	0.000674	CcSEcCtD
Rotigotine—Insomnia—Epirubicin—pancreatic cancer	0.00023	0.000671	CcSEcCtD
Rotigotine—Skin disorder—Doxorubicin—pancreatic cancer	0.000228	0.000667	CcSEcCtD
Rotigotine—Paraesthesia—Epirubicin—pancreatic cancer	0.000228	0.000667	CcSEcCtD
Rotigotine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000227	0.000664	CcSEcCtD
Rotigotine—Somnolence—Epirubicin—pancreatic cancer	0.000226	0.00066	CcSEcCtD
Rotigotine—Anorexia—Doxorubicin—pancreatic cancer	0.000224	0.000655	CcSEcCtD
Rotigotine—Nausea—Docetaxel—pancreatic cancer	0.000224	0.000654	CcSEcCtD
Rotigotine—Dyspepsia—Epirubicin—pancreatic cancer	0.000223	0.000654	CcSEcCtD
Rotigotine—Decreased appetite—Epirubicin—pancreatic cancer	0.000221	0.000645	CcSEcCtD
Rotigotine—Hypotension—Doxorubicin—pancreatic cancer	0.000219	0.000642	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000219	0.000641	CcSEcCtD
Rotigotine—Fatigue—Epirubicin—pancreatic cancer	0.000219	0.00064	CcSEcCtD
Rotigotine—Pain—Epirubicin—pancreatic cancer	0.000217	0.000635	CcSEcCtD
Rotigotine—Constipation—Epirubicin—pancreatic cancer	0.000217	0.000635	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000214	0.000626	CcSEcCtD
Rotigotine—Insomnia—Doxorubicin—pancreatic cancer	0.000212	0.000621	CcSEcCtD
Rotigotine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000211	0.000617	CcSEcCtD
Rotigotine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000209	0.000612	CcSEcCtD
Rotigotine—Somnolence—Doxorubicin—pancreatic cancer	0.000209	0.000611	CcSEcCtD
Rotigotine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000207	0.000605	CcSEcCtD
Rotigotine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000204	0.000597	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000203	0.000593	CcSEcCtD
Rotigotine—Fatigue—Doxorubicin—pancreatic cancer	0.000203	0.000592	CcSEcCtD
Rotigotine—Urticaria—Epirubicin—pancreatic cancer	0.000202	0.00059	CcSEcCtD
Rotigotine—Pain—Doxorubicin—pancreatic cancer	0.000201	0.000587	CcSEcCtD
Rotigotine—Constipation—Doxorubicin—pancreatic cancer	0.000201	0.000587	CcSEcCtD
Rotigotine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000194	0.000566	CcSEcCtD
Rotigotine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000187	0.000547	CcSEcCtD
Rotigotine—Urticaria—Doxorubicin—pancreatic cancer	0.000187	0.000546	CcSEcCtD
Rotigotine—Asthenia—Epirubicin—pancreatic cancer	0.000182	0.000533	CcSEcCtD
Rotigotine—Pruritus—Epirubicin—pancreatic cancer	0.00018	0.000525	CcSEcCtD
Rotigotine—Diarrhoea—Epirubicin—pancreatic cancer	0.000174	0.000508	CcSEcCtD
Rotigotine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000173	0.000506	CcSEcCtD
Rotigotine—Asthenia—Doxorubicin—pancreatic cancer	0.000169	0.000493	CcSEcCtD
Rotigotine—Dizziness—Epirubicin—pancreatic cancer	0.000168	0.000491	CcSEcCtD
Rotigotine—Pruritus—Doxorubicin—pancreatic cancer	0.000166	0.000486	CcSEcCtD
Rotigotine—Vomiting—Epirubicin—pancreatic cancer	0.000161	0.000472	CcSEcCtD
Rotigotine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000161	0.00047	CcSEcCtD
Rotigotine—Rash—Epirubicin—pancreatic cancer	0.00016	0.000468	CcSEcCtD
Rotigotine—Dermatitis—Epirubicin—pancreatic cancer	0.00016	0.000468	CcSEcCtD
Rotigotine—Headache—Epirubicin—pancreatic cancer	0.000159	0.000465	CcSEcCtD
Rotigotine—Dizziness—Doxorubicin—pancreatic cancer	0.000155	0.000454	CcSEcCtD
Rotigotine—Nausea—Epirubicin—pancreatic cancer	0.000151	0.000441	CcSEcCtD
Rotigotine—Vomiting—Doxorubicin—pancreatic cancer	0.000149	0.000437	CcSEcCtD
Rotigotine—Rash—Doxorubicin—pancreatic cancer	0.000148	0.000433	CcSEcCtD
Rotigotine—Dermatitis—Doxorubicin—pancreatic cancer	0.000148	0.000433	CcSEcCtD
Rotigotine—Headache—Doxorubicin—pancreatic cancer	0.000147	0.00043	CcSEcCtD
Rotigotine—Nausea—Doxorubicin—pancreatic cancer	0.00014	0.000408	CcSEcCtD
Rotigotine—DRD2—Signaling by GPCR—PIK3CB—pancreatic cancer	2.44e-05	0.000139	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PIK3CD—pancreatic cancer	2.43e-05	0.000139	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HIF1A—pancreatic cancer	2.43e-05	0.000139	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EGF—pancreatic cancer	2.43e-05	0.000139	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TSC2—pancreatic cancer	2.43e-05	0.000138	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—AKT1—pancreatic cancer	2.42e-05	0.000138	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.41e-05	0.000137	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—KDR—pancreatic cancer	2.41e-05	0.000137	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.41e-05	0.000137	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—KRAS—pancreatic cancer	2.38e-05	0.000136	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—APOE—pancreatic cancer	2.37e-05	0.000135	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—CXCL8—pancreatic cancer	2.34e-05	0.000134	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—KDR—pancreatic cancer	2.33e-05	0.000133	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CD44—pancreatic cancer	2.31e-05	0.000132	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—SRC—pancreatic cancer	2.3e-05	0.000131	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NFKBIA—pancreatic cancer	2.29e-05	0.000131	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—EGFR—pancreatic cancer	2.27e-05	0.00013	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NOTCH1—pancreatic cancer	2.27e-05	0.000129	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—VEGFA—pancreatic cancer	2.24e-05	0.000128	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—EGFR—pancreatic cancer	2.24e-05	0.000128	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TERT—pancreatic cancer	2.23e-05	0.000127	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—STAT3—pancreatic cancer	2.22e-05	0.000127	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3CG—pancreatic cancer	2.22e-05	0.000127	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—NRAS—pancreatic cancer	2.22e-05	0.000127	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—NRAS—pancreatic cancer	2.22e-05	0.000126	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NFKBIA—pancreatic cancer	2.21e-05	0.000126	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GCG—pancreatic cancer	2.21e-05	0.000126	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.19e-05	0.000125	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EGF—pancreatic cancer	2.19e-05	0.000125	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NOTCH1—pancreatic cancer	2.19e-05	0.000125	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PIK3CD—pancreatic cancer	2.19e-05	0.000125	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—PIK3CA—pancreatic cancer	2.19e-05	0.000125	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.17e-05	0.000124	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PIK3CD—pancreatic cancer	2.16e-05	0.000123	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—KRAS—pancreatic cancer	2.14e-05	0.000122	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CG—pancreatic cancer	2.14e-05	0.000122	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—NRAS—pancreatic cancer	2.14e-05	0.000122	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.14e-05	0.000122	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HIF1A—pancreatic cancer	2.14e-05	0.000122	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TSC2—pancreatic cancer	2.13e-05	0.000122	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PIK3CB—pancreatic cancer	2.12e-05	0.000121	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EGF—pancreatic cancer	2.12e-05	0.000121	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—KRAS—pancreatic cancer	2.12e-05	0.000121	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	2.09e-05	0.000119	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—APOE—pancreatic cancer	2.08e-05	0.000119	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—STK11—pancreatic cancer	2.08e-05	0.000119	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MYC—pancreatic cancer	2.06e-05	0.000118	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TGFB1—pancreatic cancer	2.06e-05	0.000117	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—DPYD—pancreatic cancer	2.05e-05	0.000117	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—KDR—pancreatic cancer	2.04e-05	0.000116	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CXCL8—pancreatic cancer	2.04e-05	0.000116	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—HRAS—pancreatic cancer	2.02e-05	0.000116	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—EGFR—pancreatic cancer	2.02e-05	0.000115	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—EGFR—pancreatic cancer	2.02e-05	0.000115	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.97e-05	0.000112	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—AKT1—pancreatic cancer	1.97e-05	0.000112	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CD44—pancreatic cancer	1.95e-05	0.000111	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—EGFR—pancreatic cancer	1.95e-05	0.000111	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3CD—pancreatic cancer	1.95e-05	0.000111	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CASP3—pancreatic cancer	1.95e-05	0.000111	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.95e-05	0.000111	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—PIK3CA—pancreatic cancer	1.94e-05	0.000111	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NFKBIA—pancreatic cancer	1.94e-05	0.000111	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.93e-05	0.00011	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NOTCH1—pancreatic cancer	1.92e-05	0.00011	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.91e-05	0.000109	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—KRAS—pancreatic cancer	1.91e-05	0.000109	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PIK3CB—pancreatic cancer	1.91e-05	0.000109	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—KRAS—pancreatic cancer	1.91e-05	0.000109	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CCND1—pancreatic cancer	1.9e-05	0.000108	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.9e-05	0.000108	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PIK3CB—pancreatic cancer	1.88e-05	0.000107	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CD—pancreatic cancer	1.88e-05	0.000107	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CG—pancreatic cancer	1.88e-05	0.000107	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—NRAS—pancreatic cancer	1.88e-05	0.000107	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CTNNB1—pancreatic cancer	1.88e-05	0.000107	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GCG—pancreatic cancer	1.87e-05	0.000107	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.87e-05	0.000106	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EGF—pancreatic cancer	1.86e-05	0.000106	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—KRAS—pancreatic cancer	1.84e-05	0.000105	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MMP9—pancreatic cancer	1.84e-05	0.000105	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CXCL8—pancreatic cancer	1.83e-05	0.000105	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PTEN—pancreatic cancer	1.83e-05	0.000105	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—HRAS—pancreatic cancer	1.82e-05	0.000104	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CXCL8—pancreatic cancer	1.81e-05	0.000103	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—HRAS—pancreatic cancer	1.8e-05	0.000103	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.79e-05	0.000102	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—AKT1—pancreatic cancer	1.79e-05	0.000102	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—AKT1—pancreatic cancer	1.77e-05	0.000101	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—STK11—pancreatic cancer	1.76e-05	0.0001	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CASP3—pancreatic cancer	1.76e-05	0.0001	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—PIK3CA—pancreatic cancer	1.75e-05	0.0001	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—PIK3CA—pancreatic cancer	1.75e-05	9.99e-05	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—AKT1—pancreatic cancer	1.75e-05	9.98e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CASP3—pancreatic cancer	1.73e-05	9.88e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—EGFR—pancreatic cancer	1.71e-05	9.78e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CCND1—pancreatic cancer	1.71e-05	9.75e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3CB—pancreatic cancer	1.7e-05	9.7e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—SRC—pancreatic cancer	1.7e-05	9.7e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TP53—pancreatic cancer	1.69e-05	9.67e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.69e-05	9.67e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CTNNB1—pancreatic cancer	1.69e-05	9.66e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CCND1—pancreatic cancer	1.69e-05	9.62e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CTNNB1—pancreatic cancer	1.67e-05	9.53e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MMP9—pancreatic cancer	1.66e-05	9.47e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—VEGFA—pancreatic cancer	1.66e-05	9.44e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CD—pancreatic cancer	1.65e-05	9.43e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.65e-05	9.43e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PTEN—pancreatic cancer	1.65e-05	9.41e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CB—pancreatic cancer	1.64e-05	9.37e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—STAT3—pancreatic cancer	1.64e-05	9.35e-05	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.64e-05	9.34e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MMP9—pancreatic cancer	1.64e-05	9.34e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NRAS—pancreatic cancer	1.63e-05	9.33e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CXCL8—pancreatic cancer	1.63e-05	9.32e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PTEN—pancreatic cancer	1.63e-05	9.29e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—HRAS—pancreatic cancer	1.62e-05	9.26e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—HRAS—pancreatic cancer	1.62e-05	9.25e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—KRAS—pancreatic cancer	1.62e-05	9.24e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—AKT1—pancreatic cancer	1.61e-05	9.18e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—AKT1—pancreatic cancer	1.59e-05	9.06e-05	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—AKT1—pancreatic cancer	1.58e-05	9.01e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CXCL8—pancreatic cancer	1.58e-05	9e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—HRAS—pancreatic cancer	1.57e-05	8.94e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CASP3—pancreatic cancer	1.56e-05	8.92e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—SRC—pancreatic cancer	1.53e-05	8.73e-05	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—AKT1—pancreatic cancer	1.52e-05	8.69e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MYC—pancreatic cancer	1.52e-05	8.69e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCND1—pancreatic cancer	1.52e-05	8.69e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TGFB1—pancreatic cancer	1.52e-05	8.67e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—TYMS—pancreatic cancer	1.51e-05	8.64e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CASP3—pancreatic cancer	1.51e-05	8.61e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—SRC—pancreatic cancer	1.51e-05	8.61e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CTNNB1—pancreatic cancer	1.51e-05	8.6e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CD44—pancreatic cancer	1.51e-05	8.6e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—VEGFA—pancreatic cancer	1.49e-05	8.5e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—EGFR—pancreatic cancer	1.49e-05	8.5e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—PIK3CA—pancreatic cancer	1.49e-05	8.49e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MMP9—pancreatic cancer	1.48e-05	8.43e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—STAT3—pancreatic cancer	1.48e-05	8.42e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NRAS—pancreatic cancer	1.47e-05	8.4e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—VEGFA—pancreatic cancer	1.47e-05	8.39e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCND1—pancreatic cancer	1.47e-05	8.39e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PTEN—pancreatic cancer	1.47e-05	8.38e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—STAT3—pancreatic cancer	1.46e-05	8.31e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CTNNB1—pancreatic cancer	1.46e-05	8.3e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—APOE—pancreatic cancer	1.45e-05	8.3e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NRAS—pancreatic cancer	1.45e-05	8.28e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GCG—pancreatic cancer	1.45e-05	8.25e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CB—pancreatic cancer	1.44e-05	8.22e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—AKT1—pancreatic cancer	1.43e-05	8.18e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—AKT1—pancreatic cancer	1.43e-05	8.16e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MMP9—pancreatic cancer	1.43e-05	8.14e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PTEN—pancreatic cancer	1.42e-05	8.09e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—KRAS—pancreatic cancer	1.41e-05	8.03e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	1.39e-05	7.9e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—AKT1—pancreatic cancer	1.38e-05	7.9e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	1.38e-05	7.85e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MYC—pancreatic cancer	1.37e-05	7.82e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TGFB1—pancreatic cancer	1.37e-05	7.8e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—SRC—pancreatic cancer	1.36e-05	7.77e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—STK11—pancreatic cancer	1.36e-05	7.75e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MYC—pancreatic cancer	1.35e-05	7.72e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TGFB1—pancreatic cancer	1.35e-05	7.7e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—EGFR—pancreatic cancer	1.34e-05	7.65e-05	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	1.34e-05	7.63e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—VEGFA—pancreatic cancer	1.33e-05	7.57e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CASP3—pancreatic cancer	1.33e-05	7.56e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EGFR—pancreatic cancer	1.32e-05	7.55e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—SRC—pancreatic cancer	1.32e-05	7.51e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—STAT3—pancreatic cancer	1.31e-05	7.5e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	1.31e-05	7.49e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NRAS—pancreatic cancer	1.31e-05	7.48e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PIK3CA—pancreatic cancer	1.29e-05	7.38e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCND1—pancreatic cancer	1.29e-05	7.36e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	1.28e-05	7.31e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	1.28e-05	7.29e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	1.27e-05	7.24e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—KRAS—pancreatic cancer	1.27e-05	7.23e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PPARG—pancreatic cancer	1.27e-05	7.23e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	1.27e-05	7.22e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	1.25e-05	7.15e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TP53—pancreatic cancer	1.25e-05	7.13e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—KRAS—pancreatic cancer	1.25e-05	7.13e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	1.25e-05	7.11e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—APOE—pancreatic cancer	1.23e-05	7.03e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MYC—pancreatic cancer	1.22e-05	6.97e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TGFB1—pancreatic cancer	1.22e-05	6.95e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	1.22e-05	6.93e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—HRAS—pancreatic cancer	1.2e-05	6.82e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EGFR—pancreatic cancer	1.19e-05	6.81e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MYC—pancreatic cancer	1.18e-05	6.73e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	1.18e-05	6.71e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.17e-05	6.67e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.17e-05	6.65e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PIK3CA—pancreatic cancer	1.16e-05	6.64e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SRC—pancreatic cancer	1.16e-05	6.59e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	1.15e-05	6.58e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	1.15e-05	6.58e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PIK3CA—pancreatic cancer	1.15e-05	6.55e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—KRAS—pancreatic cancer	1.13e-05	6.44e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TP53—pancreatic cancer	1.13e-05	6.42e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	1.12e-05	6.42e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	1.11e-05	6.36e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	1.11e-05	6.34e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	1.11e-05	6.34e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TP53—pancreatic cancer	1.11e-05	6.34e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	1.09e-05	6.21e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HRAS—pancreatic cancer	1.08e-05	6.14e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.07e-05	6.12e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HRAS—pancreatic cancer	1.06e-05	6.06e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—AKT1—pancreatic cancer	1.06e-05	6.03e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3CA—pancreatic cancer	1.04e-05	5.91e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MYC—pancreatic cancer	1.04e-05	5.91e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	1.03e-05	5.89e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	1.01e-05	5.78e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.01e-05	5.74e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TP53—pancreatic cancer	1e-05	5.72e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	1e-05	5.71e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	9.96e-06	5.68e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	9.77e-06	5.58e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TP53—pancreatic cancer	9.68e-06	5.52e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HRAS—pancreatic cancer	9.59e-06	5.47e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	9.56e-06	5.46e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—AKT1—pancreatic cancer	9.51e-06	5.42e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—APOE—pancreatic cancer	9.51e-06	5.42e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—AKT1—pancreatic cancer	9.38e-06	5.35e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	9.26e-06	5.28e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	8.79e-06	5.01e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTEN—pancreatic cancer	8.69e-06	4.96e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	8.58e-06	4.89e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	8.52e-06	4.86e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TP53—pancreatic cancer	8.5e-06	4.85e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—AKT1—pancreatic cancer	8.47e-06	4.83e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	8.44e-06	4.82e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PPARG—pancreatic cancer	8.28e-06	4.72e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	8.18e-06	4.66e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	8.13e-06	4.64e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	7.54e-06	4.3e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTEN—pancreatic cancer	7.36e-06	4.2e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	7.18e-06	4.1e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	6.57e-06	3.75e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	6.51e-06	3.72e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	6.13e-06	3.5e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTEN—pancreatic cancer	5.68e-06	3.24e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	5.19e-06	2.96e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—AKT1—pancreatic cancer	5.01e-06	2.86e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—AKT1—pancreatic cancer	4.24e-06	2.42e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	4.01e-06	2.29e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—AKT1—pancreatic cancer	3.27e-06	1.87e-05	CbGpPWpGaD
